Dr. Jamil Asselah and a panel of surgeons and medical oncologists review key SABCS 2025 Day 2 highlights, including axillary surgery de-escalation trials, updates from PATINA and HER2CLIMB-05, evolving first-line HER2+ strategies, and new data shaping imaging, endocrine therapy, and brain metastasis management.
